{"id":"https://openalex.org/W2946983618","doi":null,"title":"Survival Benefit in Multiple Myeloma With Continuous Therapy","display_name":"Survival Benefit in Multiple Myeloma With Continuous Therapy","alternate_titles":[],"publication_year":2014,"publication_date":"2014-09-04","ids":{"openalex":"https://openalex.org/W2946983618","mag":"2946983618"},"language":"en","primary_location":{"id":"mag:2946983618","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/multiple-myeloma/survival-benefit-multiple-myeloma-continuous-therapy","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2946983618"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111948575","display_name":"Leah Lawrence","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Leah Lawrence","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111948575"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.972000002861023},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/continuous-treatment","display_name":"continuous treatment","score":0.824999988079071},{"id":"https://openalex.org/keywords/transplant-ineligible-patients","display_name":"transplant-ineligible patients","score":0.9399999976158142},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9929999709129333},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6408487558364868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4161073863506317},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.4147370457649231},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.2894507348537445},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22757211327552795}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2946983618","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/multiple-myeloma/survival-benefit-multiple-myeloma-continuous-therapy","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2939570999","https://openalex.org/W2770291955","https://openalex.org/W3092332842","https://openalex.org/W2141105112","https://openalex.org/W4256097662","https://openalex.org/W2187420183","https://openalex.org/W2041386862","https://openalex.org/W2936318869","https://openalex.org/W2014558226","https://openalex.org/W2938494499"],"abstract_inverted_index":{"Continuous":[0],"treatment":[1],"with":[2],"lenalidomide":[3],"plus":[4],"dexamethasone":[5],"improved":[6],"progression-free":[7],"and":[8],"overall":[9],"survival":[10],"in":[11],"transplant-ineligible":[12],"multiple":[13],"myeloma":[14],"patients.":[15]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2946983618","counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-07T00:00:00"}
